Table 5.
All subjects (n = 239) | CAD (n = 140) | nonCAD (n = 99) | ||||
---|---|---|---|---|---|---|
r | P | r | P | r | P | |
BMI | −0.147 | 0.028 | −0.160 | 0.064 | −0.103 | 0.328 |
plasma apoCIII (log-transformed) | 0.069 | 0.302 | 0.023 | 0.791 | 0.134 | 0.204 |
apoCIIIHDL (log-transformed) | −0.241 | 0.0002 | −0.158 | 0.068 | −0.247 | 0.018 |
apoCIIIHDL ratio | −0.318 | <0.0001 | −0.199 | 0.021 | −0.409 | <0.0001 |
hsCRP (log-transformed) | −0.248 | 0.0002 | −0.205 | 0.019 | −0.237 | 0.025 |
apoAI | 0.541 | <0.0001 | 0.585 | <0.0001 | 0.442 | <0.0001 |
HDL-C (log-transformed) | 0.443 | <0.0001 | 0.448 | <0.0001 | 0.373 | 0.0003 |
CAD indicates coronary artery disease; BMI, body mass index; apoCIII, apolipoprotein CIII; hsCRP, high sensitivity C reactive protein; apoAI, apolipoprotein AI; HDL-C, high-density lipoprotein-cholesterol.